The global Infectious Disease In Vitro Diagnostics market was valued at million in 2024 and is projected to reach US$ million by 2032, at a CAGR of %during the forecast period.
The global industry is witnessing growth due to the factors, such as the growing geriatric population susceptible to infectious diseases, high demand for PoC testing owing to the pandemic, rising awareness about early testing, and rising prevalence of infectious diseases.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
We have surveyed the Infectious Disease In Vitro Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Infectious Disease In Vitro Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infectious Disease In Vitro Diagnostics. This report contains market size and forecasts of Infectious Disease In Vitro Diagnostics in global, including the following market information:
Global Infectious Disease In Vitro Diagnostics market revenue, 2020-2025, 2026-2032, ($ millions)
Global top five Infectious Disease In Vitro Diagnostics companies in 2024 (%)
Total Market by Segment:
Global Infectious Disease In Vitro Diagnostics market, by Type, 2020-2025, 2026-2032 ($ millions)
Global Infectious Disease In Vitro Diagnostics market segment percentages, by Type, 2024 (%)
Instruments
Reagents
Global Infectious Disease In Vitro Diagnostics market, by Application, 2020-2025, 2026-2032 ($ millions)
Global Infectious Disease In Vitro Diagnostics market segment percentages, by Application, 2024 (%)
Hospitals & Clinics
Diagnostic Laboratories
Others
Global Infectious Disease In Vitro Diagnostics market, by region and country, 2020-2025, 2026-2032 ($ millions)
Global Infectious Disease In Vitro Diagnostics market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Infectious Disease In Vitro Diagnostics revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Infectious Disease In Vitro Diagnostics revenues share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
QIAGEN
BD
bioM�rieux SA
F. Hoffmann-La Roche, Ltd.
Hologic, Inc. (Gen-Probe)
Abbott
Quidel Corp.
Siemens Healthineers AG
Bio-Rad Laboratories, Inc.
Danaher Corp.
OraSure Technologies, Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Infectious Disease In Vitro Diagnostics, market overview.
Chapter 2: Global Infectious Disease In Vitro Diagnostics market size in revenue.
Chapter 3: Detailed analysis of Infectious Disease In Vitro Diagnostics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Infectious Disease In Vitro Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Infectious Disease In Vitro Diagnostics Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Infectious Disease In Vitro Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Infectious Disease In Vitro Diagnostics Overall Market Size
2.1 Global Infectious Disease In Vitro Diagnostics Market Size: 2024 VS 2032
2.2 Global Infectious Disease In Vitro Diagnostics Market Size, Prospects & Forecasts: 2020-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Infectious Disease In Vitro Diagnostics Players in Global Market
3.2 Top Global Infectious Disease In Vitro Diagnostics Companies Ranked by Revenue
3.3 Global Infectious Disease In Vitro Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Infectious Disease In Vitro Diagnostics Companies in Global Market, by Revenue in 2024
3.5 Global Companies Infectious Disease In Vitro Diagnostics Product Type
3.6 Tier 1, Tier 2, and Tier 3 Infectious Disease In Vitro Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 Infectious Disease In Vitro Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 Infectious Disease In Vitro Diagnostics Companies
4 Sights by Product
4.1 Overview
4.1.1 Segmentation by Type - Global Infectious Disease In Vitro Diagnostics Market Size Markets, 2024 & 2032
4.1.2 Instruments
4.1.3 Reagents
4.2 Segmentation by Type - Global Infectious Disease In Vitro Diagnostics Revenue & Forecasts
4.2.1 Segmentation by Type - Global Infectious Disease In Vitro Diagnostics Revenue, 2020-2025
4.2.2 Segmentation by Type - Global Infectious Disease In Vitro Diagnostics Revenue, 2026-2032
4.2.3 Segmentation by Type - Global Infectious Disease In Vitro Diagnostics Revenue Market Share, 2020-2032
5 Sights by Application
5.1 Overview
5.1.1 Segmentation by Application - Global Infectious Disease In Vitro Diagnostics Market Size, 2024 & 2032
5.1.2 Hospitals & Clinics
5.1.3 Diagnostic Laboratories
5.1.4 Others
5.2 Segmentation by Application - Global Infectious Disease In Vitro Diagnostics Revenue & Forecasts
5.2.1 Segmentation by Application - Global Infectious Disease In Vitro Diagnostics Revenue, 2020-2025
5.2.2 Segmentation by Application - Global Infectious Disease In Vitro Diagnostics Revenue, 2026-2032
5.2.3 Segmentation by Application - Global Infectious Disease In Vitro Diagnostics Revenue Market Share, 2020-2032
6 Sights by Region
6.1 By Region - Global Infectious Disease In Vitro Diagnostics Market Size, 2024 & 2032
6.2 By Region - Global Infectious Disease In Vitro Diagnostics Revenue & Forecasts
6.2.1 By Region - Global Infectious Disease In Vitro Diagnostics Revenue, 2020-2025
6.2.2 By Region - Global Infectious Disease In Vitro Diagnostics Revenue, 2026-2032
6.2.3 By Region - Global Infectious Disease In Vitro Diagnostics Revenue Market Share, 2020-2032
6.3 North America
6.3.1 By Country - North America Infectious Disease In Vitro Diagnostics Revenue, 2020-2032
6.3.2 United States Infectious Disease In Vitro Diagnostics Market Size, 2020-2032
6.3.3 Canada Infectious Disease In Vitro Diagnostics Market Size, 2020-2032
6.3.4 Mexico Infectious Disease In Vitro Diagnostics Market Size, 2020-2032
6.4 Europe
6.4.1 By Country - Europe Infectious Disease In Vitro Diagnostics Revenue, 2020-2032
6.4.2 Germany Infectious Disease In Vitro Diagnostics Market Size, 2020-2032
6.4.3 France Infectious Disease In Vitro Diagnostics Market Size, 2020-2032
6.4.4 U.K. Infectious Disease In Vitro Diagnostics Market Size, 2020-2032
6.4.5 Italy Infectious Disease In Vitro Diagnostics Market Size, 2020-2032
6.4.6 Russia Infectious Disease In Vitro Diagnostics Market Size, 2020-2032
6.4.7 Nordic Countries Infectious Disease In Vitro Diagnostics Market Size, 2020-2032
6.4.8 Benelux Infectious Disease In Vitro Diagnostics Market Size, 2020-2032
6.5 Asia
6.5.1 By Region - Asia Infectious Disease In Vitro Diagnostics Revenue, 2020-2032
6.5.2 China Infectious Disease In Vitro Diagnostics Market Size, 2020-2032
6.5.3 Japan Infectious Disease In Vitro Diagnostics Market Size, 2020-2032
6.5.4 South Korea Infectious Disease In Vitro Diagnostics Market Size, 2020-2032
6.5.5 Southeast Asia Infectious Disease In Vitro Diagnostics Market Size, 2020-2032
6.5.6 India Infectious Disease In Vitro Diagnostics Market Size, 2020-2032
6.6 South America
6.6.1 By Country - South America Infectious Disease In Vitro Diagnostics Revenue, 2020-2032
6.6.2 Brazil Infectious Disease In Vitro Diagnostics Market Size, 2020-2032
6.6.3 Argentina Infectious Disease In Vitro Diagnostics Market Size, 2020-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Infectious Disease In Vitro Diagnostics Revenue, 2020-2032
6.7.2 Turkey Infectious Disease In Vitro Diagnostics Market Size, 2020-2032
6.7.3 Israel Infectious Disease In Vitro Diagnostics Market Size, 2020-2032
6.7.4 Saudi Arabia Infectious Disease In Vitro Diagnostics Market Size, 2020-2032
6.7.5 UAE Infectious Disease In Vitro Diagnostics Market Size, 2020-2032
7 Companies Profiles
7.1 QIAGEN
7.1.1 QIAGEN Corporate Summary
7.1.2 QIAGEN Business Overview
7.1.3 QIAGEN Infectious Disease In Vitro Diagnostics Major Product Offerings
7.1.4 QIAGEN Infectious Disease In Vitro Diagnostics Revenue in Global Market (2020-2025)
7.1.5 QIAGEN Key News & Latest Developments
7.2 BD
7.2.1 BD Corporate Summary
7.2.2 BD Business Overview
7.2.3 BD Infectious Disease In Vitro Diagnostics Major Product Offerings
7.2.4 BD Infectious Disease In Vitro Diagnostics Revenue in Global Market (2020-2025)
7.2.5 BD Key News & Latest Developments
7.3 bioM�rieux SA
7.3.1 bioM�rieux SA Corporate Summary
7.3.2 bioM�rieux SA Business Overview
7.3.3 bioM�rieux SA Infectious Disease In Vitro Diagnostics Major Product Offerings
7.3.4 bioM�rieux SA Infectious Disease In Vitro Diagnostics Revenue in Global Market (2020-2025)
7.3.5 bioM�rieux SA Key News & Latest Developments
7.4 F. Hoffmann-La Roche, Ltd.
7.4.1 F. Hoffmann-La Roche, Ltd. Corporate Summary
7.4.2 F. Hoffmann-La Roche, Ltd. Business Overview
7.4.3 F. Hoffmann-La Roche, Ltd. Infectious Disease In Vitro Diagnostics Major Product Offerings
7.4.4 F. Hoffmann-La Roche, Ltd. Infectious Disease In Vitro Diagnostics Revenue in Global Market (2020-2025)
7.4.5 F. Hoffmann-La Roche, Ltd. Key News & Latest Developments
7.5 Hologic, Inc. (Gen-Probe)
7.5.1 Hologic, Inc. (Gen-Probe) Corporate Summary
7.5.2 Hologic, Inc. (Gen-Probe) Business Overview
7.5.3 Hologic, Inc. (Gen-Probe) Infectious Disease In Vitro Diagnostics Major Product Offerings
7.5.4 Hologic, Inc. (Gen-Probe) Infectious Disease In Vitro Diagnostics Revenue in Global Market (2020-2025)
7.5.5 Hologic, Inc. (Gen-Probe) Key News & Latest Developments
7.6 Abbott
7.6.1 Abbott Corporate Summary
7.6.2 Abbott Business Overview
7.6.3 Abbott Infectious Disease In Vitro Diagnostics Major Product Offerings
7.6.4 Abbott Infectious Disease In Vitro Diagnostics Revenue in Global Market (2020-2025)
7.6.5 Abbott Key News & Latest Developments
7.7 Quidel Corp.
7.7.1 Quidel Corp. Corporate Summary
7.7.2 Quidel Corp. Business Overview
7.7.3 Quidel Corp. Infectious Disease In Vitro Diagnostics Major Product Offerings
7.7.4 Quidel Corp. Infectious Disease In Vitro Diagnostics Revenue in Global Market (2020-2025)
7.7.5 Quidel Corp. Key News & Latest Developments
7.8 Siemens Healthineers AG
7.8.1 Siemens Healthineers AG Corporate Summary
7.8.2 Siemens Healthineers AG Business Overview
7.8.3 Siemens Healthineers AG Infectious Disease In Vitro Diagnostics Major Product Offerings
7.8.4 Siemens Healthineers AG Infectious Disease In Vitro Diagnostics Revenue in Global Market (2020-2025)
7.8.5 Siemens Healthineers AG Key News & Latest Developments
7.9 Bio-Rad Laboratories, Inc.
7.9.1 Bio-Rad Laboratories, Inc. Corporate Summary
7.9.2 Bio-Rad Laboratories, Inc. Business Overview
7.9.3 Bio-Rad Laboratories, Inc. Infectious Disease In Vitro Diagnostics Major Product Offerings
7.9.4 Bio-Rad Laboratories, Inc. Infectious Disease In Vitro Diagnostics Revenue in Global Market (2020-2025)
7.9.5 Bio-Rad Laboratories, Inc. Key News & Latest Developments
7.10 Danaher Corp.
7.10.1 Danaher Corp. Corporate Summary
7.10.2 Danaher Corp. Business Overview
7.10.3 Danaher Corp. Infectious Disease In Vitro Diagnostics Major Product Offerings
7.10.4 Danaher Corp. Infectious Disease In Vitro Diagnostics Revenue in Global Market (2020-2025)
7.10.5 Danaher Corp. Key News & Latest Developments
7.11 OraSure Technologies, Inc.
7.11.1 OraSure Technologies, Inc. Corporate Summary
7.11.2 OraSure Technologies, Inc. Business Overview
7.11.3 OraSure Technologies, Inc. Infectious Disease In Vitro Diagnostics Major Product Offerings
7.11.4 OraSure Technologies, Inc. Infectious Disease In Vitro Diagnostics Revenue in Global Market (2020-2025)
7.11.5 OraSure Technologies, Inc. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Infectious Disease In Vitro Diagnostics Market Opportunities & Trends in Global Market
Table 2. Infectious Disease In Vitro Diagnostics Market Drivers in Global Market
Table 3. Infectious Disease In Vitro Diagnostics Market Restraints in Global Market
Table 4. Key Players of Infectious Disease In Vitro Diagnostics in Global Market
Table 5. Top Infectious Disease In Vitro Diagnostics Players in Global Market, Ranking by Revenue (2024)
Table 6. Global Infectious Disease In Vitro Diagnostics Revenue by Companies, (US$, Mn), 2020-2025
Table 7. Global Infectious Disease In Vitro Diagnostics Revenue Share by Companies, 2020-2025
Table 8. Global Companies Infectious Disease In Vitro Diagnostics Product Type
Table 9. List of Global Tier 1 Infectious Disease In Vitro Diagnostics Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Infectious Disease In Vitro Diagnostics Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segmentation by Type � Global Infectious Disease In Vitro Diagnostics Revenue, (US$, Mn), 2024 & 2032
Table 12. Segmentation by Type - Global Infectious Disease In Vitro Diagnostics Revenue (US$, Mn), 2020-2025
Table 13. Segmentation by Type - Global Infectious Disease In Vitro Diagnostics Revenue (US$, Mn), 2026-2032
Table 14. Segmentation by Application� Global Infectious Disease In Vitro Diagnostics Revenue, (US$, Mn), 2024 & 2032
Table 15. Segmentation by Application - Global Infectious Disease In Vitro Diagnostics Revenue, (US$, Mn), 2020-2025
Table 16. Segmentation by Application - Global Infectious Disease In Vitro Diagnostics Revenue, (US$, Mn), 2026-2032
Table 17. By Region� Global Infectious Disease In Vitro Diagnostics Revenue, (US$, Mn), 2024 & 2032
Table 18. By Region - Global Infectious Disease In Vitro Diagnostics Revenue, (US$, Mn), 2020-2025
Table 19. By Region - Global Infectious Disease In Vitro Diagnostics Revenue, (US$, Mn), 2026-2032
Table 20. By Country - North America Infectious Disease In Vitro Diagnostics Revenue, (US$, Mn), 2020-2025
Table 21. By Country - North America Infectious Disease In Vitro Diagnostics Revenue, (US$, Mn), 2026-2032
Table 22. By Country - Europe Infectious Disease In Vitro Diagnostics Revenue, (US$, Mn), 2020-2025
Table 23. By Country - Europe Infectious Disease In Vitro Diagnostics Revenue, (US$, Mn), 2026-2032
Table 24. By Region - Asia Infectious Disease In Vitro Diagnostics Revenue, (US$, Mn), 2020-2025
Table 25. By Region - Asia Infectious Disease In Vitro Diagnostics Revenue, (US$, Mn), 2026-2032
Table 26. By Country - South America Infectious Disease In Vitro Diagnostics Revenue, (US$, Mn), 2020-2025
Table 27. By Country - South America Infectious Disease In Vitro Diagnostics Revenue, (US$, Mn), 2026-2032
Table 28. By Country - Middle East & Africa Infectious Disease In Vitro Diagnostics Revenue, (US$, Mn), 2020-2025
Table 29. By Country - Middle East & Africa Infectious Disease In Vitro Diagnostics Revenue, (US$, Mn), 2026-2032
Table 30. QIAGEN Corporate Summary
Table 31. QIAGEN Infectious Disease In Vitro Diagnostics Product Offerings
Table 32. QIAGEN Infectious Disease In Vitro Diagnostics Revenue (US$, Mn) & (2020-2025)
Table 33. QIAGEN Key News & Latest Developments
Table 34. BD Corporate Summary
Table 35. BD Infectious Disease In Vitro Diagnostics Product Offerings
Table 36. BD Infectious Disease In Vitro Diagnostics Revenue (US$, Mn) & (2020-2025)
Table 37. BD Key News & Latest Developments
Table 38. bioM�rieux SA Corporate Summary
Table 39. bioM�rieux SA Infectious Disease In Vitro Diagnostics Product Offerings
Table 40. bioM�rieux SA Infectious Disease In Vitro Diagnostics Revenue (US$, Mn) & (2020-2025)
Table 41. bioM�rieux SA Key News & Latest Developments
Table 42. F. Hoffmann-La Roche, Ltd. Corporate Summary
Table 43. F. Hoffmann-La Roche, Ltd. Infectious Disease In Vitro Diagnostics Product Offerings
Table 44. F. Hoffmann-La Roche, Ltd. Infectious Disease In Vitro Diagnostics Revenue (US$, Mn) & (2020-2025)
Table 45. F. Hoffmann-La Roche, Ltd. Key News & Latest Developments
Table 46. Hologic, Inc. (Gen-Probe) Corporate Summary
Table 47. Hologic, Inc. (Gen-Probe) Infectious Disease In Vitro Diagnostics Product Offerings
Table 48. Hologic, Inc. (Gen-Probe) Infectious Disease In Vitro Diagnostics Revenue (US$, Mn) & (2020-2025)
Table 49. Hologic, Inc. (Gen-Probe) Key News & Latest Developments
Table 50. Abbott Corporate Summary
Table 51. Abbott Infectious Disease In Vitro Diagnostics Product Offerings
Table 52. Abbott Infectious Disease In Vitro Diagnostics Revenue (US$, Mn) & (2020-2025)
Table 53. Abbott Key News & Latest Developments
Table 54. Quidel Corp. Corporate Summary
Table 55. Quidel Corp. Infectious Disease In Vitro Diagnostics Product Offerings
Table 56. Quidel Corp. Infectious Disease In Vitro Diagnostics Revenue (US$, Mn) & (2020-2025)
Table 57. Quidel Corp. Key News & Latest Developments
Table 58. Siemens Healthineers AG Corporate Summary
Table 59. Siemens Healthineers AG Infectious Disease In Vitro Diagnostics Product Offerings
Table 60. Siemens Healthineers AG Infectious Disease In Vitro Diagnostics Revenue (US$, Mn) & (2020-2025)
Table 61. Siemens Healthineers AG Key News & Latest Developments
Table 62. Bio-Rad Laboratories, Inc. Corporate Summary
Table 63. Bio-Rad Laboratories, Inc. Infectious Disease In Vitro Diagnostics Product Offerings
Table 64. Bio-Rad Laboratories, Inc. Infectious Disease In Vitro Diagnostics Revenue (US$, Mn) & (2020-2025)
Table 65. Bio-Rad Laboratories, Inc. Key News & Latest Developments
Table 66. Danaher Corp. Corporate Summary
Table 67. Danaher Corp. Infectious Disease In Vitro Diagnostics Product Offerings
Table 68. Danaher Corp. Infectious Disease In Vitro Diagnostics Revenue (US$, Mn) & (2020-2025)
Table 69. Danaher Corp. Key News & Latest Developments
Table 70. OraSure Technologies, Inc. Corporate Summary
Table 71. OraSure Technologies, Inc. Infectious Disease In Vitro Diagnostics Product Offerings
Table 72. OraSure Technologies, Inc. Infectious Disease In Vitro Diagnostics Revenue (US$, Mn) & (2020-2025)
Table 73. OraSure Technologies, Inc. Key News & Latest Developments
List of Figures
Figure 1. Infectious Disease In Vitro Diagnostics Product Picture
Figure 2. Infectious Disease In Vitro Diagnostics Segment by Type in 2024
Figure 3. Infectious Disease In Vitro Diagnostics Segment by Application in 2024
Figure 4. Global Infectious Disease In Vitro Diagnostics Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Infectious Disease In Vitro Diagnostics Market Size: 2024 VS 2032 (US$, Mn)
Figure 7. Global Infectious Disease In Vitro Diagnostics Revenue: 2020-2032 (US$, Mn)
Figure 8. The Top 3 and 5 Players Market Share by Infectious Disease In Vitro Diagnostics Revenue in 2024
Figure 9. Segmentation by Type � Global Infectious Disease In Vitro Diagnostics Revenue, (US$, Mn), 2024 & 2032
Figure 10. Segmentation by Type - Global Infectious Disease In Vitro Diagnostics Revenue Market Share, 2020-2032
Figure 11. Segmentation by Application � Global Infectious Disease In Vitro Diagnostics Revenue, (US$, Mn), 2024 & 2032
Figure 12. Segmentation by Application - Global Infectious Disease In Vitro Diagnostics Revenue Market Share, 2020-2032
Figure 13. By Region - Global Infectious Disease In Vitro Diagnostics Revenue Market Share, 2020-2032
Figure 14. By Country - North America Infectious Disease In Vitro Diagnostics Revenue Market Share, 2020-2032
Figure 15. United States Infectious Disease In Vitro Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 16. Canada Infectious Disease In Vitro Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 17. Mexico Infectious Disease In Vitro Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 18. By Country - Europe Infectious Disease In Vitro Diagnostics Revenue Market Share, 2020-2032
Figure 19. Germany Infectious Disease In Vitro Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 20. France Infectious Disease In Vitro Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 21. U.K. Infectious Disease In Vitro Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 22. Italy Infectious Disease In Vitro Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 23. Russia Infectious Disease In Vitro Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 24. Nordic Countries Infectious Disease In Vitro Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 25. Benelux Infectious Disease In Vitro Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 26. By Region - Asia Infectious Disease In Vitro Diagnostics Revenue Market Share, 2020-2032
Figure 27. China Infectious Disease In Vitro Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 28. Japan Infectious Disease In Vitro Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 29. South Korea Infectious Disease In Vitro Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 30. Southeast Asia Infectious Disease In Vitro Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 31. India Infectious Disease In Vitro Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 32. By Country - South America Infectious Disease In Vitro Diagnostics Revenue Market Share, 2020-2032
Figure 33. Brazil Infectious Disease In Vitro Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 34. Argentina Infectious Disease In Vitro Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 35. By Country - Middle East & Africa Infectious Disease In Vitro Diagnostics Revenue Market Share, 2020-2032
Figure 36. Turkey Infectious Disease In Vitro Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 37. Israel Infectious Disease In Vitro Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 38. Saudi Arabia Infectious Disease In Vitro Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 39. UAE Infectious Disease In Vitro Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 40. QIAGEN Infectious Disease In Vitro Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 41. BD Infectious Disease In Vitro Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 42. bioM�rieux SA Infectious Disease In Vitro Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 43. F. Hoffmann-La Roche, Ltd. Infectious Disease In Vitro Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 44. Hologic, Inc. (Gen-Probe) Infectious Disease In Vitro Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 45. Abbott Infectious Disease In Vitro Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 46. Quidel Corp. Infectious Disease In Vitro Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 47. Siemens Healthineers AG Infectious Disease In Vitro Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 48. Bio-Rad Laboratories, Inc. Infectious Disease In Vitro Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 49. Danaher Corp. Infectious Disease In Vitro Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 50. OraSure Technologies, Inc. Infectious Disease In Vitro Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
